QNRX Quoin Pharmaceuticals, Ltd. ADRs

Quoin Pharmaceuticals Ltd is a pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others. This is an ADR of a company that does not have its stock publicly traded anywhere else in the world.

$2.62  -0.30 (-10.27%)
As of 09/26/2022 14:04:32 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  Israel
Country of incorporation:  
IPO date:  10/28/2021
Outstanding shares:  4,796,067
Average volume:  558,016
Market cap:   $14,004,516
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   41.92
PS ratio:   0.00
Return on equity:   -2,722.37%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy